Athenahealth blows past Q1 expectations, looks to carve out appeal amid vertical mergers

Fresh off a strong quarter in which it saw a double-digit increase in revenue compared to last year, Athenahealth (NYSE: ATHN) has its eyes fixed on changes across the healthcare industry and the role it might play in vertical consolidation. Asked about how the company plans to navigate new, potentially influential mergers like CVS-Aetna and the Amazon, JPMorgan, Berkshire Hathaway partnership, CEO Jonathan Bush noted that the success of those new partnerships will hinge on the ability to coordinate care for a larger swath of patients.